Physician profile
Rachel Eve Koransky-Matson
NPI 1407307861
$15,957.02
in general payments reported to CMS, 2019-2025
19 companies · $9,157 in 2025
The $9,157 reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,404 · 2023: $3,089 · 2024: $1,308 · 2025: $9,157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,200 · Food and Beverage: $3,932 · Travel and Lodging: $2,171 · Long Term Medical Supply Or Device Loan: $160 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,200.00 |
| Food and Beverage | $3,932.23 |
| Travel and Lodging | $2,170.91 |
| Long Term Medical Supply Or Device Loan | $159.93 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $7,849.86 | 2024-2025 | Mounjaro |
| Medtronic, INC. | $4,462.41 | 2022-2024 | Minimed 780g, Intellis Adaptivestim, Minimed 770g |
| Dexcom, INC. | $749.17 | 2022-2025 | Dexcom G6 Transmitter, Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Abbott Laboratories | $685.99 | 2023-2024 | Freestyle Libre 3, Freestyle Copilot, Freestyle Insulinx |
| Tandem Diabetes Care, INC. | $600.24 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Astrazeneca Pharmaceuticals Lp | $563.30 | 2022-2024 | Lokelma, Farxiga, Airsupra |
| Novo Nordisk INC | $210.52 | 2022-2024 | Ozempic, Rybelsus |
| Beta Bionics, INC. | $152.13 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Sequel Med Tech, LLC | $123.70 | 2025 | Twiist |
| Supernus Pharmaceuticals, INC. | $121.36 | 2025 | Qelbree |
| Sanofi-Aventis U.S. LLC | $103.68 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $89.99 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.10 | 2024-2025 | Jardiance |
| Amgen INC. | $50.26 | 2025 | Evenity |
| Averitas Pharma INC. | $40.17 | 2025 | Qutenza |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $36.06 | 2023-2024 | Gvoke Hypopen |
| Exact Sciences Corporation | $26.43 | 2025 | The Cologuard Plus Collection Kit |
| Corcept Therapeutics | $25.16 | 2025 | Korlym |
| Insulet Corporation | $13.49 | 2024 | Omnipod |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Koransky-Matson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.